Literature DB >> 11214728

Alpha- and gamma-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine.

J K Lodge1, J Ridlington, S Leonard, H Vaule, M G Traber.   

Abstract

Limited information is available regarding metabolism of vitamin E forms, especially the tocotrienols. Carboxyethyl-hydroxychromans (alpha- and gamma-CEHC) are human urinary metabolites of alpha- and gamma-tocopherols, respectively. To evaluate whether tocotrienols are also metabolized and excreted as urinary CEHC, urine was monitored following tocotrienol supplementation. Complete (24 h) urine collections were obtained for 2 d prior to (baseline), the day of, and 2 d after human subjects (n = 6) ingested tocotrienol supplements. The subjects consumed 125 mg gamma-tocotrienyl acetate the first week, then the next week 500 mg; then 125 mg alpha-tocotrienyl acetate was administered the third week, followed by 500 mg the fourth week. Urinary alpha- and gamma-CEHC were measured by high-performance liquid chromatography with electrochemical detection. Urinary gamma-CEHC levels rose about four- to sixfold in response to the two doses of gamma-tocotrienol and then returned to baseline the following day. Significant (P < 0.0001) increases in urinary alpha-CEHC were observed only following ingestion of 500 mg alpha-tocotrienyl acetate. Typically, 1-2% of alpha-tocotrienyl acetates or 4-6% of gamma-tocotrienyl acetates were recovered as their respective urinary CEHC metabolites. A gamma-CEHC excretion time course showed an increase in urinary gamma-CEHC at 6 h and a peak at 9 h following ingestion of 125 mg gamma-tocotrienyl acetate. In summary, tocotrienols, like tocopherols, are metabolized to CEHC; however, the quantities excreted in human urine are small in relation to dose size.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11214728     DOI: 10.1007/s11745-001-0666-z

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  23 in total

1.  Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol.

Authors:  E Serbinova; V Kagan; D Han; L Packer
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

2.  Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs.

Authors:  A Hosomi; M Arita; Y Sato; C Kiyose; T Ueda; O Igarashi; H Arai; K Inoue
Journal:  FEBS Lett       Date:  1997-06-02       Impact factor: 4.124

3.  The absorption of alpha-tocopherol in man.

Authors:  J Kelleher; M S Losowsky
Journal:  Br J Nutr       Date:  1970-12       Impact factor: 3.718

4.  Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee).

Authors:  A A Qureshi; N Qureshi; J J Wright; Z Shen; G Kramer; A Gapor; Y H Chong; G DeWitt; A Ong; D M Peterson
Journal:  Am J Clin Nutr       Date:  1991-04       Impact factor: 7.045

5.  Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice.

Authors:  D J Mustacich; J Shields; R A Horton; M K Brown; D J Reed
Journal:  Arch Biochem Biophys       Date:  1998-02-15       Impact factor: 4.013

6.  Urinary alpha-tocopherol metabolites in alpha-tocopherol transfer protein-deficient patients.

Authors:  M Schuelke; A Elsner; B Finckh; A Kohlschütter; C Hübner; R Brigelius-Flohé
Journal:  J Lipid Res       Date:  2000-10       Impact factor: 5.922

7.  Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates.

Authors:  M G Traber; A Elsner; R Brigelius-Flohé
Journal:  FEBS Lett       Date:  1998-10-16       Impact factor: 4.124

8.  Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: observations in humans and hamsters.

Authors:  K C Hayes; A Pronczuk; J S Liang
Journal:  Proc Soc Exp Biol Med       Date:  1993-03

9.  Biological potencies of epsilon- and zeta-1-tocopherol and 5-methyltocol.

Authors:  J BUNYAN; D McHALE; J GREEN; S MARCINKIEWICZ
Journal:  Br J Nutr       Date:  1961       Impact factor: 3.718

10.  Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?

Authors:  M Schultz; M Leist; M Petrzika; B Gassmann; R Brigelius-Flohé
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

View more
  18 in total

Review 1.  Complexity of vitamin E metabolism.

Authors:  Lisa Schmölz; Marc Birringer; Stefan Lorkowski; Maria Wallert
Journal:  World J Biol Chem       Date:  2016-02-26

2.  Tissue distribution of α- and γ-tocotrienol and γ-tocopherol in rats and interference with their accumulation by α-tocopherol.

Authors:  Tomono Uchida; Chisato Abe; Saki Nomura; Tomio Ichikawa; Saiko Ikeda
Journal:  Lipids       Date:  2011-11-01       Impact factor: 1.880

Review 3.  Tocotrienols: Vitamin E beyond tocopherols.

Authors:  Chandan K Sen; Savita Khanna; Sashwati Roy
Journal:  Life Sci       Date:  2006-02-03       Impact factor: 5.037

4.  Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E.

Authors:  Valentina Viola; Francesca Pilolli; Marta Piroddi; Elisa Pierpaoli; Fiorenza Orlando; Mauro Provinciali; Michele Betti; Francesco Mazzini; Francesco Galli
Journal:  Genes Nutr       Date:  2011-04-20       Impact factor: 5.523

5.  Gamma-tocotrienol and gamma-tocopherol are primarily metabolized to conjugated 2-(beta-carboxyethyl)-6-hydroxy-2,7,8-trimethylchroman and sulfated long-chain carboxychromanols in rats.

Authors:  Helene Freiser; Qing Jiang
Journal:  J Nutr       Date:  2009-03-18       Impact factor: 4.798

6.  α-Tocopherol does not accelerate depletion of γ-tocopherol and tocotrienol or excretion of their metabolites in rats.

Authors:  Tomono Uchida; Saki Nomura; Eri Sakuma; Fumiaki Hanzawa; Saiko Ikeda
Journal:  Lipids       Date:  2013-05-23       Impact factor: 1.880

7.  Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients.

Authors:  Kylie Sherée Smith; Chia-Lin Lee; James W Ridlington; Scott W Leonard; Sridevi Devaraj; Maret G Traber
Journal:  Lipids       Date:  2003-08       Impact factor: 1.880

Review 8.  Tocotrienols: the emerging face of natural vitamin E.

Authors:  Chandan K Sen; Savita Khanna; Cameron Rink; Sashwati Roy
Journal:  Vitam Horm       Date:  2007       Impact factor: 3.421

9.  Cytochrome P450-dependent metabolism of vitamin E isoforms is a critical determinant of their tissue concentrations in rats.

Authors:  Chisato Abe; Tomono Uchida; Moeka Ohta; Tomio Ichikawa; Kanae Yamashita; Saiko Ikeda
Journal:  Lipids       Date:  2007-05-23       Impact factor: 1.880

10.  Urinary α-carboxyethyl hydroxychroman can be used as a predictor of α-tocopherol adequacy, as demonstrated in the Energetics Study.

Authors:  Katie M Lebold; Alfonso Ang; Maret G Traber; Lenore Arab
Journal:  Am J Clin Nutr       Date:  2012-09-05       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.